Patent Yard Sign in
Expired European patentEurope

Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof

EP 0957109 B1 · Applicant: Aventis Pharmaceuticals Inc.

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 20, 1995 and granted May 6, 2004. A European patent lasts at most 20 years from filing, so its term ended November 20, 2015.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by May 20, 2021.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledNovember 20, 1995
PublishedNovember 17, 1999
GrantedMay 6, 2004
Term endedNovember 20, 2015
Application numberEP 99114227
Classification (CPC)C07D471/04 +2 more

Timeline

Timeline From EPO dates

1996199820002002200420062008201020122014Application filedNov 20, 1995PublishedNov 17, 1999Patent grantedMay 6, 2004Term endedNov 20, 2015

Sources & verification